product summary
company name :
Cell Signaling Technology
product type :
antibody
product name :
MAVS Antibody (Rodent Specific)
catalog :
4983S
quantity :
100 ul
price :
235 USD
clonality :
polyclonal
host :
rabbit
reactivity :
human, mouse, rat
application :
western blot, immunocytochemistry, immunoprecipitation
citations: 2
Published Application/Species/DilutionReference
  • western blot; human
Ailenberg M, Di Ciano-Oliveira C, Szaszi K, Dan Q, Rozycki M, Kapus A, et al. Dynasore enhances the formation of mitochondrial antiviral signalling aggregates and endocytosis-independent NF-κB activation. Br J Pharmacol. 2015;172:3748-63 pubmed publisher
  • western blot; mouse; 1:1000
Chen J, Zhao Y, Zhang C, Chen H, Feng J, Chi X, et al. Persistent hepatitis C virus infections and hepatopathological manifestations in immune-competent humanized mice. Cell Res. 2014;24:1050-66 pubmed publisher
product information
SKU :
4983S
Product-Name :
MAVS Antibody (Rodent Specific)
Size :
100 ul
Price-(USD) :
235 USD
Species-x-Reactivity :
M, R
Applications :
Immunofluorescence (Immunocytochemistry)
Product-Category :
Immunology and Inflammation
Shipping-Temp :
AMBIENT
Storage-Temp :
-20°C
Product-Type :
Polyclonal Antibody
MW :
75, 52
Host :
Rabbit
Target :
MAVS
Primary-Protein :
MAVS
Alt-Names :
CARD adapter inducing interferon beta,CARD adapter inducing interferon-beta,CARD adaptor inducing IFN-beta,Cardif,DKFZp547C224,DKFZp666M015,FLJ27482,FLJ35386,FLJ38051,FLJ41962,IFN-B promoter stimulator 1,IPS-1,IPS1,Interferon beta promoter stimulator protein 1,KIAA1271,MAVS,MGC3260,Mitochondrial antiviral-signaling protein,Putative NF-kappa-B-activating protein 031N,VISA,Virus-induced-signaling adapter,interferon-beta promoter stimulator protein 1,mitochondrial anti-viral signaling protein,mitochondrial antiviral signaling protein,virus-induced signaling adapter variant 1b,virus-induced signaling adaptor variant 1a
company information
Cell Signaling Technology
3 Trask Lane
Danvers, MA 01923
info@cellsignal.com
www.cellsignal.com
8776162355
headquarters: USA
Established in Beverly, MA in 1999, Cell Signaling Technology (CST) is a privately-owned company with over 400 employees worldwide. We are dedicated to providing innovative research tools that are used to help define mechanisms underlying cell function and disease. Since its inception, CST has become the world leader in the production of the highest quality activation-state and total protein antibodies utilized to expand knowledge of cell signaling pathways. Our mission is to deliver the world's highest quality research tools that accelerate progress in biological research and personalized medicine.